Page last updated: 2024-10-31

mirtazapine and Bleeding

mirtazapine has been researched along with Bleeding in 3 studies

Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.

Research Excerpts

ExcerptRelevanceReference
"To report a case of warfarinization involving a patient who developed nasal bleeding and an elevated prothrombin time-international normalized ratio (PT-INR) after taking 15 mg of mirtazapine."3.81[A Case with the Increased PT-INR after the Addition of Mirtazapine to Warfarin Therapy]. ( Kawakami, M; Nishimura, H, 2015)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bixby, AL1
VandenBerg, A1
Bostwick, JR1
Nishimura, H1
Kawakami, M1
Al-Adwani, A1

Reviews

1 review available for mirtazapine and Bleeding

ArticleYear
Clinical Management of Bleeding Risk With Antidepressants.
    The Annals of pharmacotherapy, 2019, Volume: 53, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Bupropion; Gastrointestinal Hemorrha

2019

Other Studies

2 other studies available for mirtazapine and Bleeding

ArticleYear
[A Case with the Increased PT-INR after the Addition of Mirtazapine to Warfarin Therapy].
    Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 2015, Volume: 117, Issue:10

    Topics: Aged; Anticoagulants; Drug Interactions; Hemorrhage; Humans; Male; Mianserin; Mirtazapine; Prothromb

2015
Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2005, Volume: 50, Issue:13

    Topics: Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Depressive Disorder, Major; Drug Resist

2005